AXA S.A. – Vertex Pharmaceuticals Incorporated Transaction History
AXA S.A. portfolio value:
$80.34M
portfolio value
AXA S.A. quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +18.63% | 43.58K shares | 14.43M | $289.54 | 277.49K |
| Q2 2022 | share | Decrease | -23.96% | -73.70K shares | -14.36M | $281.79 | 233.91K |
| Q1 2022 | share | Decrease | -24.27% | -98.58K shares | -8.92M | $260.97 | 307.61K |
| Q4 2021 | share | Decrease | -3.72% | -15.69K shares | 12.67M | $222.45 | 406.19K |
| Q3 2021 | share | Increase | +89.24% | 198.95K shares | 31.57M | $181.39 | 421.88K |
| Q2 2021 | share | Decrease | -5.04% | -11.82K shares | -5.49M | $201.63 | 222.93K |
| Q1 2021 | share | Decrease | -24.05% | -74.32K shares | -22.60M | $214.89 | 234.75K |
| Q4 2020 | share | Decrease | -9.08% | -30.87K shares | -19.46M | $236.34 | 309.08K |
| Q3 2020 | share | Decrease | -27.88% | -131.44K shares | -44.34M | $272.12 | 339.96K |
| Q2 2020 | share | Increase | +10.98% | 46.65K shares | 35.78M | $290.31 | 471.40K |
| Q1 2020 | share | Increase | +6.43% | 25.64K shares | 13.68M | $237.95 | 424.75K |
| Q4 2019 | share | Increase | +37.17% | 108.14K shares | 38.09M | $218.95 | 399.10K |
| Q3 2019 | share | Decrease | -36.80% | -169.43K shares | -35.13M | $169.42 | 290.95K |
| Q2 2019 | share | Decrease | -14.33% | -76.97K shares | -14.42M | $183.38 | 460.38K |
| Q1 2019 | share | Decrease | -2.77% | -15.29K shares | 7.26M | $183.95 | 537.36K |
| Q4 2018 | share | Increase | +3.77% | 20.08K shares | -11.06M | $165.71 | 552.65K |
| Q3 2018 | share | Decrease | -33.77% | -271.50K shares | -34.01M | $192.74 | 532.57K |
| Q2 2018 | share | Increase | +16.69% | 114.99K shares | 24.35M | $169.96 | 804.08K |
| Q1 2018 | share | Increase | +162.90% | 426.97K shares | 73.02M | $162.98 | 689.08K |
| Q4 2017 | share | Decrease | -4.41% | -12.08K shares | -2.40M | $149.86 | 262.11K |
| Q3 2017 | share | Increase | +60.30% | 103.14K shares | 19.64M | $152.04 | 274.19K |
| Q2 2017 | share | Decrease | -3.32% | -5.88K shares | 2.69M | $128.87 | 171.04K |
| Q1 2017 | share | Decrease | -64.81% | -325.85K shares | -17.69M | $109.35 | 176.92K |
| Q4 2016 | share | Decrease | -11.42% | -64.80K shares | -12.46M | $73.67 | 502.78K |
| Q3 2016 | share | Decrease | -9.93% | -62.58K shares | -4.70M | $87.21 | 567.59K |
| Q2 2016 | share | Increase | +11.43% | 64.65K shares | 9.25M | $86.02 | 630.17K |
| Q1 2016 | share | Decrease | -9.57% | -59.82K shares | -33.73M | $79.49 | 565.51K |